Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: News/

Jan 19, 2007 04:59AM

Re: News/

posted on Jan 19, 2007 05:05AM

"the Company repurchased 4,874,827 shares for the first six months ended November 30, 2006 at an aggregate cost of $4,024,395, and in December 2006 and January 2007 purchased 3,132,500 shares at an aggregate cost of $1,960,305. Patriot Scientific had 381,214,818 common shares outstanding on January 12, 2007."

I find this to be encouraging. I see this action (by the company through its board) as confirmation of their belief in the high prospects for PTSC and as support for remaining shareholders. Thanks for a new slant on previous news. Did Hoffman just put out this PR or ?

Share
New Message
Please login to post a reply